Capital Flow Monitor · Sponsors · CIK 2078601
Cirrus Therapeutics, Inc.
750 Main Street, Cambridge, MA, 02139 · (617) 959-3124
Other Technology · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$15.7M
Sold
$6.7M
% sold
42.7%
Investors
8
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-19 | D ·current | 506(b) | $15.7M | $6.7M | 42.7% | 8 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Ying Kai Chan — Executive Officer / Director / Promoter, Cambridge, MA
- Andrew Dick — Director / Promoter, Cambridge, MA
-
Alexandra Cantley — Director, Cambridge, MA
3 other raises
- Auron Therapeutics, Inc. $27.3M of $42.3M · 64.5%
- Polaris Partners XI, L.P. $0 of $500.0M · 0.0%
- Crossbow Therapeutics, Inc. $30.3M of $80.0M · 37.8%
- Khoo Shih — Director, Cambridge, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.